Speciality Medicines
Speciality Medicines Share Price Chart
Speciality Medicines last traded at ₹166.10 (2026-10-13). Over the past month the stock moved +4.4%, three months the stock moved -27.9%. Its closing range over 52 weeks is ₹125.90 – ₹363.05, with the latest close 54.2% below the high.
Closing prices up to 2026-10-13.
About Speciality Medicines
Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals.[1]
Business Profile[1] Co. is engaged in the marketing and distribution of specialty pharmaceutical formulations, with a focus on high-cost oral and injectable drugs across key therapeutic areas including oncology, immunology, neurology, and rare diseases.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 45.00 | 8.00 | 19.00 | 8.00 | 9.31 |
| Mar 2025 | 31.00 | 4.00 | 14.00 | 3.00 | 4.16 |
Annual Financials
In the latest year (Mar 2026), Speciality Medicines reported sales of ₹75.00 crore (+28.7%) and net profit of ₹13.00 crore (+51.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 75.00 | 14.00 | 18.00 | 13.00 | 14.83 |
| Mar 2025 | 58.27 | 9.13 | 15.67 | 8.61 | 13.38 |
| Mar 2024 | 27.52 | 5.28 | 19.19 | 2.93 | 5.73 |
| Mar 2023 | 23.24 | 3.58 | 15.40 | 1.69 | 4.42 |
| Mar 2022 | 40.44 | 2.28 | 5.64 | 1.48 | 70.48 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | -42.5% | +18.4% | +111.7% | +28.7% |
| Operating profit growth | +57.0% | +47.5% | +72.9% | +53.3% |
| Net profit growth | +14.2% | +73.4% | +193.9% | +51.0% |
| EPS growth | -93.7% | +29.6% | +133.5% | +10.8% |
| OPM % | 15.4% | 19.2% | 15.7% | 18.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Speciality Medicines.
Get Free AI Stock Analysis FREE →Latest News
-
Speciality Medicines gets regulatory approval for two new products in Ethiopia
-
Speciality Medicines inks commercial agreement valued at USD 2 million - Business Standard
-
Speciality Medicines climbs after securing $2 million overseas order - Business Standard
-
Speciality Medicines inks commercial agreement valued at USD 2 million - Business Standard
-
Speciality Medicines climbs after securing $2 million overseas order - Business Standard
-
Speciality Medicines inks commercial agreement valued at USD 2 million - Business Standard
-
Speciality Medicines inks commercial agreement valued at USD 2 million - Business Standard
-
Speciality Medicines climbs after securing $2 million overseas order - Business Standard
-
Speciality Medicines inks commercial agreement valued at USD 2 million - Business Standard
-
Speciality Medicines touches roof on finalizing commercial arrangement to market product
Frequently Asked Questions
What is Speciality Medicines's current stock price?
Speciality Medicines shares were last quoted at ₹166.10 (-1.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Speciality Medicines?
Speciality Medicines has a price-to-earnings (P/E) ratio of 11.12 and a price-to-book (P/B) ratio of 2.04. The industry P/E is 53.33.
What is the 52-week high and low of Speciality Medicines?
The 52-week high of Speciality Medicines is ₹381.20 and the 52-week low is ₹121.10.
What is the market cap of Speciality Medicines?
The market capitalisation of Speciality Medicines is about ₹144.88 crore.
Is Speciality Medicines a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Speciality Medicines has a 3-year ROE of 29.00%, 3-year profit growth of 98.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Speciality Medicines?
Promoters hold about 43.43% of Speciality Medicines.
Which sector does Speciality Medicines belong to?
Speciality Medicines belongs to the Pharmaceuticals & Drugs sector.